BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 18501572)

  • 1. Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology.
    San Román B; Irache JM; Gómez S; Tsapis N; Gamazo C; Espuelas MS
    Eur J Pharm Biopharm; 2008 Sep; 70(1):98-108. PubMed ID: 18501572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-delivery of ovalbumin and CpG motifs into microparticles protected sensitized mice from anaphylaxis.
    San Román B; Irache JM; Gómez S; Gamazo C; Espuelas S
    Int Arch Allergy Immunol; 2009; 149(2):111-8. PubMed ID: 19127067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of a balanced Th1/Th2 immune responses by co-delivery of PLGA/ovalbumin nanospheres and CpG ODNs/PEI-SWCNT nanoparticles as TLR9 agonist in BALB/c mice.
    Ebrahimian M; Hashemi M; Maleki M; Abnous K; Hashemitabar G; Ramezani M; Haghparast A
    Int J Pharm; 2016 Dec; 515(1-2):708-720. PubMed ID: 27989827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses.
    Wusiman A; Gu P; Liu Z; Xu S; Zhang Y; Hu Y; Liu J; Wang D; Huang X
    Int J Nanomedicine; 2019; 14():3221-3234. PubMed ID: 31123399
    [No Abstract]   [Full Text] [Related]  

  • 5. Surface coating of PLGA microparticles with protamine enhances their immunological performance through facilitated phagocytosis.
    Martínez Gómez JM; Csaba N; Fischer S; Sichelstiel A; Kündig TM; Gander B; Johansen P
    J Control Release; 2008 Sep; 130(2):161-7. PubMed ID: 18588928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intradermal vaccination with hollow microneedles: A comparative study of various protein antigen and adjuvant encapsulated nanoparticles.
    Du G; Hathout RM; Nasr M; Nejadnik MR; Tu J; Koning RI; Koster AJ; Slütter B; Kros A; Jiskoot W; Bouwstra JA; Mönkäre J
    J Control Release; 2017 Nov; 266():109-118. PubMed ID: 28943194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen.
    Mutwiri G; Benjamin P; Soita H; Babiuk LA
    Vaccine; 2008 May; 26(22):2680-8. PubMed ID: 18430493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen.
    Borges O; Silva M; de Sousa A; Borchard G; Junginger HE; Cordeiro-da-Silva A
    Int Immunopharmacol; 2008 Dec; 8(13-14):1773-80. PubMed ID: 18801462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
    Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J
    J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of neonatal sublingual vaccination with native or denatured ovalbumin and adjuvant CpG or cholera toxin on systemic and mucosal immunity in mice.
    Huang CF; Wu TC; Chu YH; Hwang KS; Wang CC; Peng HJ
    Scand J Immunol; 2008 Nov; 68(5):502-10. PubMed ID: 18822109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-administration of CpG oligonucleotides and chenopodium album extract reverse IgG2a/IgG1 ratios and increase IFN-gamma and IL-10 productions in a murine model of asthma.
    Mousavi T; Salek Moghadam A; Falak R; Tebyanian M
    Iran J Allergy Asthma Immunol; 2008 Mar; 7(1):1-6. PubMed ID: 18322305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platycodin D2 is a potential less hemolytic saponin adjuvant eliciting Th1 and Th2 immune responses.
    Xie Y; Deng W; Sun H; Li D
    Int Immunopharmacol; 2008 Aug; 8(8):1143-50. PubMed ID: 18550019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of chitosan nanoparticles and chitosan hydrogels for vaccine delivery.
    Gordon S; Saupe A; McBurney W; Rades T; Hook S
    J Pharm Pharmacol; 2008 Dec; 60(12):1591-600. PubMed ID: 19000363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(gamma-glutamic acid) nanoparticles as an efficient antigen delivery and adjuvant system: potential for an AIDS vaccine.
    Wang X; Uto T; Akagi T; Akashi M; Baba M
    J Med Virol; 2008 Jan; 80(1):11-9. PubMed ID: 18041033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angelica sinensis polysaccharide encapsulated into PLGA nanoparticles as a vaccine delivery and adjuvant system for ovalbumin to promote immune responses.
    Gu P; Liu Z; Sun Y; Ou N; Hu Y; Liu J; Wu Y; Wang D
    Int J Pharm; 2019 Jan; 554():72-80. PubMed ID: 30399435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG ODN mediated prevention from ovalbumin-induced anaphylaxis in mouse through B cell pathway.
    Xu W; Tamura T; Takatsu K
    Int Immunopharmacol; 2008 Feb; 8(2):351-61. PubMed ID: 18182251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual dye in-vivo imaging of differentially charged PLGA carriers reveals antigen-depot effect, leading to improved immune responses in preclinical models.
    Riehl M; Harms M; Lucas H; Ebensen T; Guzmán CA; Mäder K
    Eur J Pharm Sci; 2018 May; 117():88-97. PubMed ID: 29408551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of MyD88 adaptor molecule and interleukin-12/interferon-gamma axis.
    Bortolatto J; Borducchi E; Rodriguez D; Keller AC; Faquim-Mauro E; Bortoluci KR; Mucida D; Gomes E; Christ A; Schnyder-Candrian S; Schnyder B; Ryffel B; Russo M
    Clin Exp Allergy; 2008 Oct; 38(10):1668-79. PubMed ID: 18631348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Water-free microencapsulation of proteins within PLGA microparticles by spray drying using PEG-assisted protein solubilization technique in organic solvent.
    Mok H; Park TG
    Eur J Pharm Biopharm; 2008 Sep; 70(1):137-44. PubMed ID: 18515053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of poly(D,L-lactide-co-glycolide) microparticles with polyelectrolyte self-assembled multilayer surfaces on the cross-presentation of exogenous antigens.
    Yang YW; Hsu PY
    Biomaterials; 2008 Jun; 29(16):2516-26. PubMed ID: 18329708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.